About Careers MedBlog Contact us

New Setback for Diabetes Drug Avandia

by VR Sreeraman on July 10, 2010 at 1:13 PM
Font : A-A+

 New Setback for Diabetes Drug Avandia

GlaxoSmithKline's blockbuster diabetes treatment Avandia suffered a new setback Friday when US health officials offered more evidence of the drug's increased link to heart problems.

A document released by the Food and Drug Administration came as an FDA panel of experts prepares to meet next week to consider withdrawing the popular drug because of concerns about its links to cardiovascular ailments.


The document cited Thomas Marciniak, an FDA expert on cardiovascular treatments, who indicated that clinical trials of the drug, whose generic name is rosiglitazone, were "inadequately designed" and that the record "suggests the rosiglitazone increases the risk" of heart attacks.

"Half of the errors were substantial," Marciniak said in the document. "If consulted in advance, I would have rejected this study design as inappropriate and biased."

The report came after two studies released in recent weeks concluded patients taking Avandia faced a higher risk of heart attacks and strokes, emboldening critics who have asked that it be withdrawn from the market.

The FDA often follows the advice of its panels of experts, which will make its recommendation after the talks on Tuesday and Wednesday.

In addition to Marciniak's comments, the FDA also released some 700 pages of documents examining studies on Avandia and its safety compared with other treatments.

Last year sales of Avandia, which has been on the market since 1999, were about 800 million dollars worldwide, making it one of the top selling diabetes treatments and overall drugs.

Source: AFP


Recommended Reading

Latest Drug News

Are Painkillers Safe for Back Pain?
Safety and effectiveness of commonly used painkillers (analgesics) for short-term relief of low back pain remain uncertain.
 India's First Urinary Incontinence Drug Launched
India's First Urinary Incontinence Drug Fesobig may offer Affordable treatment for Overactive Bladder (OAB), a widely prevalent problem among Indian men and women.
 New Ray of Hope for Atrial Fibrillation Patients With Kidney Disease
Oral anticoagulant drugs, particularly Rivaroxaban presented superior efficacy and safety than warfarin in atrial fibrillation patients with chronic kidney disease.
Anti-viral Drug Bulevirtide Helps Treat Chronic Hepatitis D
Patients with hepatitis D virus-related chronic advanced liver disease are treated with an antiviral therapy.
Antiviral Drug Paxlovid Linked to Lower Risk of Hospital Admission
Among people with COVID-19, Paxlovid drug was found to reduce hospitalization and death risk by 90%, revealed study.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

New Setback for Diabetes Drug Avandia Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests